Page last updated: 2024-08-16

xylazine and 3-cyclopentyloxy-4-methoxybenzaldehyde

xylazine has been researched along with 3-cyclopentyloxy-4-methoxybenzaldehyde in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argellati, F; Balbi, A; Bollen, E; Brullo, C; Bruno, O; Canepa, E; Cavallero, A; Domenicotti, C; Erb, K; Fedele, E; Gardella, E; Gijselaers, HJ; Limebeer, CL; Marinari, UM; Parker, LA; Prickaerts, J; Pronzato, MA; Ricciarelli, R; Vanmierlo, T1

Other Studies

1 other study(ies) available for xylazine and 3-cyclopentyloxy-4-methoxybenzaldehyde

ArticleYear
GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses.
    British journal of pharmacology, 2011, Volume: 164, Issue:8

    Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hippocampus; Imines; Ketamine; Male; Memory; Mice; Mice, Inbred C57BL; Morpholines; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Rats, Wistar; Xylazine

2011